Valuation dashboard for Neogen Corporation (NEOG) with P/E N/A, P/B 1.26, EV/EBITDA 19.27 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed.
Analysis Summary
Neogen Corporation reported revenue of $870.4M in the most recent fiscal year, growing at a 5-year CAGR of 13.2%.
Trailing-twelve-month margins: gross margin 46.9%, operating margin -2.5%, net margin -0.9%.
At the current price of $13.01, NEOG has negative trailing earnings (P/E not meaningful) and an ROE of -0.37%. Market capitalisation stands at $2.8B.
Balance sheet quality for NEOG: current ratio of 3.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.26 |
| EV / EBITDA | 19.27 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-1.95 |
| vs Current Price | -115.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| NEOG | Neogen Corporation | $2.6B | 1.26 | -0.4% | |
| ABT | Abbott Laboratories | $168.7B | 31.35 | 3.33 | 12.5% |
| 0Y6X.L | Medtronic Plc | $118.6B | |||
| MDT | Medtronic plc | $110.6B | 21.28 | 2.20 | 9.7% |
| 0R2S.L | Stryker Corporation | $106.3B | 29.31 | 4.56 | 16.4% |
| SYK | Stryker Corporation | $105.6B | 28.54 | 4.40 | 14.5% |
| 0HOY.L | Boston Scientific Corporation | $65.0B | |||
| BSX | Boston Scientific Corporation | $63.3B | 17.18 | 2.52 | 11.9% |
Price
| Price | $13.01 |
| Market Cap | $2.8B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -0.37% |
| Return on Invested Capital | -0.60% |
| Return on Assets | -0.24% |
| Gross Margin | 46.93% |
| Operating Margin | -2.49% |
| Net Margin | -0.91% |
Related companies: AZTA · BLFS · CNMD · KMTS · NTLA · NVCR · OPK
Explore sector: Healthcare · Medical - Devices
More sections of NEOG: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks